It is uncommon for risk groups defined by statistical or artificial intelligence (AI) models to be chosen by jointly considering model performance and potential interventions available. We develop a framework to rapidly guide choice…
Continue Reading
What You Should Know:
– Boehringer Ingelheim and IBM announced a collaboration to leverage IBM’s foundation model technologies for the discovery of novel candidate antibodies in drug development.
– The partnership will focus on utilizing IBM’s…
Continue Reading
What You Should Know: Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications that assist in diagnosing cancer, announced it has teamed up with Nuance, a Microsoft company, to create the largest digital…
Continue Reading
By Shania Kennedy
November 28, 2023 – Researchers from the UCLA Health Jonsson Comprehensive Cancer Center have created an artificial intelligence (AI) model that can successfully predict cancer survival outcomes by analyzing epigenetic factors, according to…
Continue Reading
Healthcare AI startup Paige is joining forces with Microsoft subsidiary Nuance to launch what they say is “the largest digital consultation network in pathology,” the companies announced Monday at RSNA 2023, the annual radiology…
Continue Reading
TeleDaaS, a Dosimetry-as-a-Service pioneer, unveils its breakthrough platform at #RSNA2023. Specializing in precision dosimetry for CROs and pharmaceuticals, TeleDaaS integrates seamlessly with imaging workflows to advance cancer treatment research. Led by Dr. Mark Crockett,…
Continue Reading
Musculoskeletal (MSK) is routinely one of the three most expensive categories of care (along with cardio-metabolic disease and cancer care). Dr. Steve Schutzer, an orthopedic surgeon for 34 years, is working on this pain point as…
Continue Reading
Careology and Nuffield Health, the UK’s largest healthcare charity, have extended their partnership to provide people undergoing cancer treatment access to advanced digital cancer care technology at 12 Nuffield Health hospitals across the UK. During…
Continue Reading
ScreenPoint Medical’s Transpara AI has analyzed 5 million mammograms and 1 million Tomosynthesis studies, spotlighting at RSNA 2023. Studies reveal its role as a ‘second pair’ of eyes aiding cancer detection, and reducing recall…
Continue Reading
AI’s prowess predicts lung cancer risk in non-smokers through routine chest X-rays. The study unveils an advanced “CXR-Lung-Risk” model, identifying 28% of participants at significantly higher risk. Dr. Lu emphasizes its pivotal role amid…
Continue Reading
